Abstract:Amr Molla, 1 Abdulfatah M Alayoubi, 2 Raed Jannadi 3 1 Department of Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia; 2 Department of Basic Medical Sciences, College of Medicine, Taibah University, Madinah, Saudi Arabia; 3 Department of Family & Community Medicine &, Medical Education, College of Medicine, Taibah University, Madinah, Saudi Arabia Correspondence: Amr Molla, Universities Road, P.O. Box: 344, Taibah, Madinah, 42353, Saudi Arabia, Tel +966504342992, Email Background: Vitiligo, a condition characterized by depigmented skin, has been observed to have a higher incidence in patients with a family history of the disease. This study investigates the relationship between parental consanguinity, family medical history, and the onset of childhood vitiligo, hypothesizing that genetic factors play a significant role. Methods: A cross-sectional study was conducted involving 382 people diagnosed with vitiligo in Saudi Arabia. The study assessed the prevalence of parental consanguinity and its correlation with the disease's onset, employing statistical analysis to evaluate the data collected through medical records and family history questionnaires. Results: The findings reveal a significant association between parental consanguinity, particularly among first cousins, and the incidence of childhood-onset vitiligo. Additionally, a notable correlation was found between family medical history and the onset of the condition, with familial vitiligo being more prevalent in patients with adult-onset vitiligo. Conclusion: This study underscores the critical role of genetic predispositions in the development of childhood-onset vitiligo, highlighting the influence of parental consanguinity. The results advocate for increased awareness and screening in populations with high rates of consanguinity to facilitate early detection and management of vitiligo. Future research should focus on exploring the genetic mechanisms underlying this association to develop targeted interventions. Keywords: parental consanguinity, childhood-onset vitiligo, genetic factors, familial vitiligo, Saudi Arabia, cross-sectional study Vitiligo manifests through the formation of distinct depigmented white macules and patches on the skin, a result of the targeted destruction of melanocytes within those areas. Accompanying autoimmune disorders, especially those related to the thyroid, are commonly observed alongside vitiligo. With a global prevalence rate of 0.5–2%, vitiligo's appearance is more pronounced on darker skin tones, though it indiscriminately affects all racial and ethnic groups. 1–4 The condition's prevalence in Saudi Arabia stands at 3.5%, slightly higher among females, attributed possibly to greater cosmetic concern reporting. The onset age in Saudi Arabia does not significantly differ from the global average of approximately 20 years, nor does it vary significantly between genders. 5 Genetic factors significantly influence the pathogenesis of vitiligo, with about 30% of affected individuals reporting a family history of the condition. 6,7 This prevalence highlights a notable genetic component, underscored by observed patterns of consanguinity linked with particular clinical subtypes of the disease. Notably, a higher incidence of vitiligo is associated with first-cousin consanguinity, particularly in cases of non-segmental and acrofacial vitiligo. The inbreeding coefficient, indicative of genetic closeness within affected families, shows a strong correlation with the prevalence of vitiligo, suggesting a robust genetic predisposition. Genetic analyses suggest that vitiligo likely follows a multifactorial inheritance pattern, involving a combination of polygenic influences and environmental factors, which collectively contribute to its manifestation. 8 In Saudi Arabia, consanguineous marriages are common in the population, which increases the prevalence of certain hereditary and rare genetic skin disorders, including vitiligo, compared to other populations. 9 Vitiligo can develop at any age, but is most frequently seen in individuals aged 10–30 years, with an average onset age of about 24 years. It can appear as early as 3 months of age, and the characteristics of vitiligo can differ between children and adults. 10,11 There has been limited research differentiating between vitiligo that begins in childhood (before 18 years) and that which starts in adulthood (after 18 years). Studies comparing the clinical aspects of vitiligo in prepubertal children and postpubertal adults are scarce. 12,13 There is an inadequate number of studies comparing various associated clinical factors with both chil -Abstract Truncated-

Inverse relationship between polygenic risk burden and age of onset of autoimmune vitiligo

Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci

Genetic Factors are Stressed Variably by Onset Age-based Sample Selection in Psoriasis: A Hint from MHC Region-based Analysis.

The relationship between psoriasis and vitiligo: From a comprehensive study

Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening

The genetic concept of vitiligo

High incidence of MTHFR, CBS, and MTRR polymorphisms in vitiligo patients. Preliminary report in a retrospective study

Validation of Susceptibility Loci for Vitiligo Identified by GWAS in the Chinese Han Population

First Cousin Marriages and the Risk of Childhood-Onset Vitiligo: Exploring the Genetic Background: A Cross-Sectional Study

Physiopathology and genetics of vitiligo

An Integrative Migraine Polygenic Risk Score Is Associated with Age at Onset But Not Chronification

The Causal Nexus of Immune Cells and Vitiligo: A Genetic Perspective

A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion

Age-of-onset Information Helps Identify 76 Genetic Variants Associated with Allergic Disease

Estimation of genetic variation in vitiligo associated genes: Population genomics perspective

Implication of regulatory T cells' telomere shortening in pathogenesis of generalized vitiligo

Late‐Onset Vitiligo: Epidemiology, Clinical Characteristics, and Management Strategies

Genome-wide Association Study for Vitiligo Identifies Susceptibility Loci at 6q27 and the MHC

Understanding mechanisms of autoimmunity through translational research in vitiligo

Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population.

550 - Vitiligo is associated with new onset osteoporosis: a population-based study